281 Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicentre experience during the COVID-19 lockdown

Autor: Alessia Bernardini, Michele Magnocavallo, Marco Valerio Mariani, Maria Chiara Mei, Martina Di Iorio, Giampaolo Vetta, Agostino Piro, Sara Trivigno, Giuseppe Giunta, Cristina Chimenti, Antonino Nicosia, Carmen Adduci, Stefano Grossi, Davide Saporito, Raffaele Quaglione, Antonio Rapacciuolo, Massimiliano Marini, Giuseppe Santarpia, Francesco Pentimalli, Roberto Rordorf, Paola Vaccaro, Monica Campari, Sergio Valsecchi, Francesco Fedele, Carlo Lavalle
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: European Heart Journal Supplements : Journal of the European Society of Cardiology
ISSN: 1554-2815
1520-765X
Popis: Aims During the COVID-19 pandemic in-person visits for patients with cardiac implantable electronic devices should be replaced by remote monitoring (RM), in order to prevent viral transmission. A direct home-delivery service of the RM communicator has been implemented at 49 Italian arrhythmia centres. Methods and results According to individual patient preference or the organizational decision of the centre, patients were assigned to the home-delivery group or the standard in-clinic delivery group. In the former case, patients received telephone training on the activation process and use of the communicator. In June 2020, the centres were asked to reply to an ad hoc questionnaire to describe and evaluate their experience in the previous 3 months. RM was activated in 1324 patients: 821 (62%) received the communicator at home and the communicator was activated remotely. Activation required one additional call in 49% of cases, and the median time needed to complete the activation process was 15 min (25th–75th percentile: 10–20). 753 (92%) patients were able to complete the correct activation of the system. At the time when the questionnaire was completed, 743 (90%) communicators were regularly transmitting data. The service was generally deemed useful (96% of respondents) in facilitating the activation of RM during the COVID-19 pandemic and possibly beyond. Conclusions Home delivery of the communicator proved to be a successful approach to system activation, and received positive feedback from clinicians. The increased use of a RM protocol will reduce risks for both providers and patients, while maintaining high-quality care.
Databáze: OpenAIRE
Externí odkaz: